Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors
Article in Cell Communication and Signaling (February 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Successful treatment with bortezomib in combination with dexamethasone in a middle-aged male with idiopathic multicentric Castleman’s disease: A case report
Article in Open Medicine (January 2024)
Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus‐based Position Paper From an ad hoc Expert Panel
Article in HemaSphere (May 2023)